Enhanced blood pressure response to mild sodium reduction in subjects with the 235T variant of the angiotensinogen gene

American Journal of Hypertension

Volumn 12, Issue 5, 1999, Pages 460-466

  Hunt, Steven C ^a   Geleijnse, Johanna M ^b   Wu, Lily L ^a   Witteman, Jacqueline C M ^b   Williams, Roger R ^a   Grobbee, Diederick E ^b,c  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Blood pressure; Clinical trial; Epidemiology; Genetics; Interaction; Magnesium; Potassium; Renin substrate

Indexed keywords

ANGIOTENSINOGEN; POTASSIUM; SODIUM;

ADULT; AGED; ALLELE; ARTICLE; BLOOD PRESSURE MONITORING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PLASMA RENIN ACTIVITY; POTASSIUM INTAKE; POTASSIUM URINE LEVEL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SALT INTAKE; SODIUM EXCRETION; SODIUM URINE LEVEL; SYSTOLIC BLOOD PRESSURE; SYSTOLIC HYPERTENSION;

AGED; ALLELES; ANGIOTENSINOGEN; BLOOD PRESSURE; DIET, SODIUM-RESTRICTED; DNA; DOUBLE-BLIND METHOD; FEMALE; FOLLOW-UP STUDIES; GENE FREQUENCY; GENOTYPE; HUMANS; HYPERTENSION; MAGNESIUM; MALE; MIDDLE AGED; POTASSIUM, DIETARY; SODIUM, DIETARY; TREATMENT OUTCOME;

EID: 0033005767     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0895-7061(99)00014-X     Document Type: Article

References (27)

1. Walker W.G., Whelton P.K., Saito H., et al. Relation between blood pressure and renin, renin substrate, angiotensin II, aldosterone and urinary sodium and potassium in 574 ambulatory subjects. Hypertension. 1:1979;287-291.
2. Jeunemaitre X., Soubrier F., Kotelevtsev Y., et al. Molecular basis of human hypertension role of angiotensinogen . Cell. 71:1992;169-180.
3. Caulfield M., Lavender P., Farrall M., et al. Linkage of the angiotensinogen gene to essential hypertension. N Engl J Med. 330:1994;1629-1633.
4. Jeunemaitre X., Inoue I., Williams C., et al. Haplotypes of angiotensinogen in essential hypertension. Am J Hum Genet. 60:1997;1448-1460.
5. Inoue I., Nakajima T., Williams C.S., et al. A nucleotide substitution in the promoter of human angiotensinogen is associated with essential hypertension and affects basal transcription in vitro. J Clin Invest. 99:1997;1786-1797.
6. Jeunemaitre X., Charru A., Chatellier G., et al. M235T variant of the human angiotensinogen gene in unselected hypertensive patients. J Hypertens. 11:(suppl 5):1993;S80-S81.
7. Hata A., Namikawa C., Sasaki M., et al. Angiotensinogen as a risk factor for essential hypertension in Japan. J Clin Invest. 93:1994;1285-1287.
8. Bloem L.J., Manatunga A.K., Tewksbury D.A., Pratt J.H. The serum angiotensinogen concentration and variants of the angiotensinogen gene in white and black children. J Clin Invest. 95:1995;948-953.
9. Iwai N., Shimoike H., Ohmichi N., Kinoshita M. Angiotensinogen gene and blood pressure in the Japanese population. Hypertension. 25:1995;688-693.
10. Borecki I.B., Province M.A., Ludwig E.H., et al. Associations of candidate loci angiotensinogen and angiotensin-converting enzyme with severe hypertension the NHLBI family heart study . Ann Epidemiol. 7:1997;13-21.
11. Schunkert H., Hense H.-W., Gimenez-Roqueplo A., et al. The angiotensinogen T235 variant and the use of antihypertensive drugs in a population-based cohort. Hypertension. 29:1997;628-633.
12. Hall J.E. Control of sodium excretion by angiotensin intrarenal mechanisms and blood pressure regulation . Am J Physiol. 250:1986;R960-R972.
13. Hunt S.C., Cook N.R., Oberman A., et al. Angiotensinogen genotype, sodium reduction, weight loss, and the prevention of hypertension Trials of Hypertension Prevention, phase II . Hypertension. 32:1998;393-401.
14. Hegele R.A., Brunt J.H., Connelly P.W. A polymorphism of the angiotensinogen gene associated with variation in blood pressure in a genetic isolate. Circulation. 90:1994;2207-2212.
15. Rotimi C., Morrison L., Cooper R., et al. Angiotensinogen gene in human hypertension. Lack of an association of the 235T allele among African Americans. Hypertension. 24:1994;591-594.
16. Fornage M., Turner S.T., Sing C.F., Boerwinkle E. Variation at the M235T locus of the angiotensinogen gene and essential hypertension a population-based case-control study from Rochester, Minnesota . Hum Genet. 96:1995;295-300.
17. Forrester T., McFarlane-Anderson N., Bennet F., et al. Angiotensinogen and blood pressure among blacks findings from a community survey in Jamaica . J Hypertens. 14:1996;315-321.
18. Hingorani A.D., Sharma P., Jia H., et al. Blood pressure and the M235T polymorphism of the angiotensinogen gene. Hypertension. 28:1996;907-911.
19. Geleijnse J.M., Witteman J.C., Bak A.A., et al. Reduction in blood pressure with a low sodium, high potassium, high magnesium salt in older subjects with mild to moderate hypertension. Br Med J. 309:1994;436-440.
20. Whelton P.K., He J., Cutler J.A., et al. Effects of oral potassium on blood pressure. Meta-analysis of randomized controlled clinical trials. JAMA. 277:1997;1624-1632.
21. Geleijnse J.M., Witteman J.C., Hofman A., Grobbee D.E. Electrolytes are associated with blood pressure at old age the Rotterdam Study . J Hum Hypertens. 11:1997;421-423.
22. Tobian L. The Volhard lecture. Potassium and sodium in hypertension. J Hypertens. 4:(suppl 6):1988;S12-S24.
23. Ascherio A., Rimm E.B., Giovannucci E.L., et al. A prospective study of nutritional factors and hypertension among US men. Circulation. 86:1992;1475-1484.
24. Joffres M.R., Reed D.M., Yano K. Relationship of magnesium intake and other dietary factors to blood pressure the Honolulu Heart Study . Am J Clin Nutr. 45:1987;469-475.
25. Hopkins P.N., Lifton R.P., Hollenberg N.K., et al. Blunted renal vascular response to angiotensin II is associated with a common variant of the angiotensinogen gene and obesity. J Hypertens. 14:1996;199-207.
26. Redgrave J., Rabinowe S., Hollenberg N.K., Williams G.H. Correction of abnormal renal blood flow response to angiotensin II by converting enzyme inhibition in essential hypertensives. J Clin Invest. 75:1985;1285-1290.
27. Hollenberg N.K., Moore T., Shoback D., et al. Abnormal renal sodium handling in essential hypertension. Relation to failure of renal and adrenal modulation of responses to angiotensin II. Am J Med. 81:1986;412-418.